Author:
Young Allan,Rucker James,Van den Eynde Vincent,Redhead Charles,Barnett Brian,Godet Lila,Cleare Anthony,Cosgrove John,Stahl Stephen,Birkenhäger Tom,Gillman Peter Kenneth
Abstract
Experienced clinicians and academics from the International MAOI (monoamine oxidase inhibitor) Expert Group comment on questions of interest concerning MAOI pharmacotherapy for depression, especially as they pertain to the illustrative case summaries presented in this part one of the Expert Roundtable Discussion. These comments focus on practical therapeutics and aspects of difficult cases that guidelines simply do not, and cannot, address, such as the important fact that psychotic depression may respond rapidly to MAOIs. The ethical and medico-legal issues relating to cost and ongoing availability are also discussed.
[
Psychiatr Ann
. 2023;53(8):359–363.]
Subject
Psychiatry and Mental health
Reference2 articles.
1. The Fake, the Flimsy, and the Fallacious: Demarcating Arguments in Real Life
2. Hypertension in orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors. [In Dutch.];Zandee WT;Tijdschr Psychiatr,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献